BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4686369)

  • 1. Insulin receptors in human circulating lymphocytes: application to the study of insulin resistance in man.
    Archer JA; Gorden P; Gavin JR; Lesniak MA; Roth J
    J Clin Endocrinol Metab; 1973 Apr; 36(4):627-33. PubMed ID: 4686369
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of radioreceptor assay to circulating insulin, growth hormone, and to their tissue receptors in animals and man.
    Gorden P; Gavin JR; Kahn CR; Archer JA; Lesniak M; Hendricks C; Neville DM; Roth J
    Pharmacol Rev; 1973 Jun; 25(2):179-87. PubMed ID: 4581041
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin receptors in human circulating cells and fibroblasts.
    Gavin JR; Roth J; Jen P; Freychet P
    Proc Natl Acad Sci U S A; 1972 Mar; 69(3):747-51. PubMed ID: 4501590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 2-deoxy-D-glucose in studying the mechanism of lipid mobilization.
    Grasso SG; Karam JH; Wegienka LC; Grodsky GM; Forsham PH
    J Clin Endocrinol Metab; 1968 Apr; 28(4):535-42. PubMed ID: 4868497
    [No Abstract]   [Full Text] [Related]  

  • 5. Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction.
    Archer JA; Gorden P; Roth J
    J Clin Invest; 1975 Jan; 55(1):166-74. PubMed ID: 1109176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic thyrotropin releasing factor as a test of pituitary thyrotropin reserve.
    Fleischer N; Lorente M; Kirkland J; Kirkland R; Clayton G; Calderon M
    J Clin Endocrinol Metab; 1972 Apr; 34(4):617-24. PubMed ID: 4335101
    [No Abstract]   [Full Text] [Related]  

  • 7. Water-soluble insulin receptors from human lymphocytes.
    Gavin JR; Buell DN; Roth J
    Science; 1972 Oct; 178(4057):168-9. PubMed ID: 4342623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relation of glycide and lipid metabolism in patients with acromegaly or hypopituitarism].
    Felt V
    Cas Lek Cesk; 1967 Aug; 106(34):914-8. PubMed ID: 5584206
    [No Abstract]   [Full Text] [Related]  

  • 9. [Specific binding of 125I-insulin by fat cell plasma membranes in acromegaly].
    Efimov AS; Bezdrobnyĭ IuV; Evdokimova NIu; Komissarenko IV; Demchenko NP
    Vopr Med Khim; 1981; 27(5):644-7. PubMed ID: 7032063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone secretion in pituitary disease.
    Nelson JC; Kollar DJ; Lewis JE
    Arch Intern Med; 1974 Mar; 133(3):459-63. PubMed ID: 4811484
    [No Abstract]   [Full Text] [Related]  

  • 11. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
    Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappearance of serum insulin in obese-hyperglycemic mice.
    Coore HG; Westman S
    Acta Physiol Scand; 1970 Feb; 78(2):274-9. PubMed ID: 5456891
    [No Abstract]   [Full Text] [Related]  

  • 13. [Observations on "clearance" of phosphorus (Cp) in acromegaly and in hypopituitarism].
    Piancino G; Modica A; Martini PF
    Boll Soc Ital Biol Sper; 1966 Apr; 42(7):369-73. PubMed ID: 5949374
    [No Abstract]   [Full Text] [Related]  

  • 14. Disappearance rate of endogenous and exogenous human growth hormone in man.
    Refetoff S; Sönksen PH
    J Clin Endocrinol Metab; 1970 Mar; 30(3):386-92. PubMed ID: 5412545
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of a single dose of L-dopa on pituitary hormones in acromegaly, obesity, and in normal subjects.
    Mims RB; Stein RB; Bethune JE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):34-9. PubMed ID: 4715294
    [No Abstract]   [Full Text] [Related]  

  • 16. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects.
    Clemmons DR; Snyder DK; Busby WH
    J Clin Endocrinol Metab; 1991 Oct; 73(4):727-33. PubMed ID: 1716260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiologic and physiopathologic implications of insulin-receptor interaction (III)].
    Durán García S; González Mateo MC
    Med Clin (Barc); 1984 May; 82(17):771-6. PubMed ID: 6429461
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth.
    MacGillivray MH; Frohman LA; Doe J
    J Clin Endocrinol Metab; 1970 May; 30(5):632-8. PubMed ID: 5444554
    [No Abstract]   [Full Text] [Related]  

  • 19. Human growth hormone. Characterization of plasma and pituitary components and application of a new radioreceptor assay.
    Gorden P; Lesniak MA; Hendricks CM; Roth J; McGuffin W; Gavin JR
    Isr J Med Sci; 1974 Oct; 10(10):1239-46. PubMed ID: 4140167
    [No Abstract]   [Full Text] [Related]  

  • 20. Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients.
    Alberti L; Gilardini L; Girola A; Moro M; Cavagnini F; Invitti C
    Diabetes Obes Metab; 2007 May; 9(3):344-9. PubMed ID: 17391161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.